Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Newland

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|August 30, 2002
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsDrew Provan, Adrian Newland
Immunotherapy|October 7, 2020
Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopeniaAdrian Newland, Vickie McDonald
Journal of Pediatric Hematology/Oncology|December 12, 2003
Idiopathic thrombocytopenic purpura in adultsDrew Provan, Adrian Newland
British Journal of Haematology|March 20, 2010
Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedsideGraham Molineux, Adrian Newland
Expert Opinion on Biological Therapy|July 27, 2021
Experts' review: the emerging roles of romiplostim in immune thrombocytopenia (ITP)Frederick Chen, Vickie McDonald, Adrian Newland
BMJ (Clinical Research Ed.)|August 20, 2005
Preventing severe infection after splenectomyAdrian Newland, Drew Provan, Steven Myint
Therapeutic Advances in Hematology|April 26, 2013
The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopeniaNichola Cooper, Ilaria Terrinoni, Adrian Newland
Annals of Hematology|September 16, 2010
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debateRoberto Stasi, Adrian Newland, Patrick Thornton, et al.
British Journal of Haematology|April 6, 2021
Thrombosis in immune thrombocytopenia - current status and future perspectivesDawn Swan, Adrian Newland, Francesco Rodeghiero, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal ViewTomás José González-López, Adrian Newland, Drew Provan
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|August 30, 2002
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsDrew Provan, Adrian Newland
Immunotherapy|October 7, 2020
Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopeniaAdrian Newland, Vickie McDonald
Journal of Pediatric Hematology/Oncology|December 12, 2003
Idiopathic thrombocytopenic purpura in adultsDrew Provan, Adrian Newland
British Journal of Haematology|March 20, 2010
Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedsideGraham Molineux, Adrian Newland
Expert Opinion on Biological Therapy|July 27, 2021
Experts' review: the emerging roles of romiplostim in immune thrombocytopenia (ITP)Frederick Chen, Vickie McDonald, Adrian Newland
BMJ (Clinical Research Ed.)|August 20, 2005
Preventing severe infection after splenectomyAdrian Newland, Drew Provan, Steven Myint
Therapeutic Advances in Hematology|April 26, 2013
The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopeniaNichola Cooper, Ilaria Terrinoni, Adrian Newland
Annals of Hematology|September 16, 2010
Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debateRoberto Stasi, Adrian Newland, Patrick Thornton, et al.
British Journal of Haematology|April 6, 2021
Thrombosis in immune thrombocytopenia - current status and future perspectivesDawn Swan, Adrian Newland, Francesco Rodeghiero, et al.
Medicina (Kaunas, Lithuania)|April 28, 2023
Current Concepts in the Diagnosis and Management of Adult Primary Immune Thrombocytopenia: Our Personal ViewTomás José González-López, Adrian Newland, Drew Provan
Pageof 5